Pseudomonas vaccine - CJ Corporation

Drug Profile

Pseudomonas vaccine - CJ Corporation

Alternative Names: CFC-101

Latest Information Update: 07 Dec 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator CJ Corporation
  • Class Bacterial vaccines; Pseudomonas vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Pseudomonal infections

Most Recent Events

  • 19 Aug 2003 Phase-III clinical trials in Pseudomonal infections in South Korea (IM)
  • 23 Dec 2002 Cheil Jedang is now called CJ Corporation
  • 14 Jun 2000 Phase-II clinical trials for Pseudomonal infections in South Korea (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top